pathology of testes tumours
TRANSCRIPT
CLINICAL PATHOLOGYThe foundation of clinical medicine.
Shashidhar Venkatesh MurthyA/Prof & Head of Pathology
College of Medicine & Dentistry
MGS4: Male Genital: Testes Tumors
CPC : Term4 Week4 - MGS 4/6System : Male Genital System.Topic : 1: Overview 2: STD 3: Orchitis 4: Tumours 5: Penis 6: GLS
3
Testes Tumors: Features: Commonest tumour of young males, painless swelling. Etiology: Idiopathic, Undescended testes (10%, 10 times) Classification:
95% Germ cell Tumours, Seminoma 45% - good prognosis. Non seminoma (NSGT) 45% - poor prognosis.
Embryonal ca, Teratoma, Chriocarcinoma, Mixed - common
5% Sertoli / Leydig cell tumours. Clinical features:
Adults 20-40y – Seminoma. Children <10y – NSGT- Yolksac tum. Painless, dragging, unilateral, solid. Metastases – Para aortic LN*.
4
Seminoma: Commonest Germ cell tumour, 20-40y. Firm, grey, smooth, painless, Many subtypes: classical*, spermatocytic etc.. Microscopy: uniform clear cells + lymphocytes. Mixed seminoma Seminoma + Teratoma, embryonal carcinoma or
choriocarcinoma (βhCG 10%). Etc.
8
NSGT: Embryonal Ca Clinical: painless swelling, hemorrhagic,
malignant, poor prognosis, metastases. Germ cell tumor – embryonic cells. Gross: Hemorrhagic, necrotic tumor. Adults: Embryonal Ca. Children: Yolksac tumor. Tumor Marker: AFP (α feto protein) Microscopy: Pleomorphic cells, embryoid
structures. Pink AFP globules in cells.
9
NSGT: Teratoma / Teratocarcinoma
> 1 tissue type (mature / immature) Teratoma + other germ cell tum (Embryonal ca) Common, 10-30y, aggressive, poor prognosis. Both βhCG & AFP +ve - if mixed.
10
Testes Tumors: summary Germ cell Tumours (95%)
Gonadal: SeminomaNon Seminoma Germ Cell tum (NSGT) Embryonic: Embryonal ca. Extraembryonic: Yolk sac tum, Choriocarcinoma. Somatic: Teratoma Mixed: (40%)
Tumor – Incidence Age Tumor MarkerSeminoma 50% 40-50y 10% βhCG
Embryonal ca. 20-30y Negative (pure)
Yolk sac tumour < 3y 90% AFP
Choriocarcinoma 20-30y 100% βhCG
Teratoma (Pure) All ages Negative
Mixed 15% 15-30y 90% βhCG & AFP